Drugging the entire human proteome: are we there yet?

Micholas Dean Smith,L. Darryl Quarles,Omar Demerdash,Jeremy C. Smith
DOI: https://doi.org/10.1016/j.drudis.2024.103891
IF: 8.369
2024-01-23
Drug Discovery Today
Abstract:Each of the ∼20 000 proteins in the human proteome is a potential target for compounds that bind to it and modify its function. The 3D structures of most of these proteins are now available. Here, we discuss the prospects for using these structures to perform proteome-wide virtual HTS (VHTS). We compare physics-based (docking) and AI VHTS approaches, some of which are now being applied with large databases of compounds to thousands of targets. Although preliminary proteome-wide screens are now...
pharmacology & pharmacy
What problem does this paper attempt to address?